Both in Pharmaceuticals
Neurogene vs MapLight Therapeutics
Over the past year NGNE returned −11.4% and MPLT returned −44.7%; their daily moves had a correlation of 0.14.
NGNE −11.4% MPLT −44.7%Growth of $1, one year, split-adjusted
| Metric | NGNE | MPLT |
|---|---|---|
| Price | $28.39 | $10.15 |
| Market cap | $568.1M | $564.1M |
| Today | −0.32% | −2.87% |
| 1 month | −22.4% | −19.4% |
| 6 months | +47.1% | −45.8% |
| Year to date | +37.8% | −42.2% |
| 1 year | +59.3% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $225.4M | $304.7M |
| Dividend yield | — | — |
| Volatility (60d) | 66.6% | 279.3% |
| Short % of float | 25.5% | 24.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).